Opens in a new tab

OrthoApnea v *** (CFI, 2 May 2025)

Date2 May 2025
CourtCFI
DivisionBrussels (BE) Local Division
Type of actionApplication For Costs
Case number(s)UPC_CFI_131/2025
Registry referenceACT_7974/2025 · ORD_8991/2025 · UPC_CFI_131/2025
PartiesOrthoApnea S.L. and Vivisol B BV (Applicants) v. ***

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

On OrthoApnea and Vivisol’s application for EUR 92,814.62 in costs following their success in the infringement action on EP 2 331 036 against an individual defendant (UPC_CFI_131/2025), the judge rapporteur Granata (Brussels Local Division) stayed the costs proceedings until the Court of Appeal rules on the merits. The rule remains that there is no stay, but fairness and the proper administration of justice justified one here.

Question

Should costs proceedings brought after a decision on the merits be stayed where that decision is under appeal?

Decision

Neither the UPCA, the Rules of Procedure nor Directive 2004/48 require a general stay. Filing an appeal will not, as a rule, justify one (paragraph 11). However, the true successful party is the one that prevails in the last instance (paragraph 12), and Rule 295(c) and (m) as well as equity allow a stay, if need be of the court’s own motion (paragraphs 13 to 17). Here, the appeal decision was expected within about twelve months, the amount did not threaten recoverability, a reversal would give rise to a new, out-of-time costs claim, and needless decisions should be avoided (paragraph 18). The parties must inform the judge rapporteur of the outcome of the appeal (paragraph 19).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 69(1) and Preamble
Rules of Procedure
Rules 150, 151, 156, 221 and 295(c) and (m)
Directive 2004/48/EC
Art. 14
Case law cited
Meril Life Sciences v Edwards Lifesciences, Court of Appeal, 18 January 2024, Court of Appeal, 29 July 2024 (UPC_CoA_1/2024), Court of Appeal, 18 April 2025 (UPC_CoA_166/2025), Brussels Local Division, 17 January 2025 (decision on the merits under appeal)

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: Court fees and costs (UPC).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_131/2025 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Application For Costs
Outcome (Dhenne Avocats summary)
La procédure de fixation des frais est suspendue jusqu'à la décision de la cour d'appel sur le fond, l'équité et la bonne administration de la justice le justifiant malgré le principe d'absence de suspension.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 2 331 036
Device for treating night time breathing problems
recorded proprietor: Personne physique (déposant individuel)
Mentioned in the analysis (role not qualified)
Also mentioned in 8 other decision(s): OrthoApnea v *** (CFI, 25 July 2025) · Appellant*** v ORTHOAPNEA (CoA, 3 July 2025) · OrthoApnea v *** (CoA, 21 November 2024) · *** v OrthoApnea (CFI, 17 September 2024) · OrthoApnea v *** (CoA, 26 July 2024) · OrthoApnea (CFI, 19 July 2024) · OrthoApnea (CFI, 8 July 2024) · *** v OrthoApnea (CFI, 21 September 2023)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.